药物开发-话题@MedSci - williamhill asia

#药物开发#

38篇内容 | 1216人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2206866, encodeId=6a8022068667c, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a> <a href='/topic/show?id=2e6e6e0315d' target=_blank style='color:#2F92EE;'>#炎症性肠病#</a> <a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=一作兼通讯，最新Nature系列综述：炎症性肠病药物开发的复杂性及其解决策略, objectType=article, longId=827738, objectId=104a82e7386d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240527/1716792810978_5579292.jpg, objectUrl=/article/show_article.do?id=104a82e7386d, replyNumber=0, likeNumber=32, createdTime=2024-05-27, rootId=0, userName=williamhill asia 管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=104a82e7386d, moduleTitle=一作兼通讯，最新Nature系列综述：炎症性肠病药物开发的复杂性及其解决策略, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=104a82e7386d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1442579, encodeId=e6ef14425e925, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=“AlphaFold像地震一样，改变了游戏规则”，如今它开始在基础研究、药物开发上全面发力, objectType=article, longId=734270, objectId=8ae7e342705f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ae7e342705f, replyNumber=0, likeNumber=65, createdTime=2022-08-04, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ae7e342705f, moduleTitle=“AlphaFold像地震一样，改变了游戏规则”，如今它开始在基础研究、药物开发上全面发力, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=8ae7e342705f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442578, encodeId=fb9d14425e87a, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=拉斯克奖得主魏斯曼全新撰文，mRNA技术应用范围会加大，将颠覆药物开发模式, objectType=article, longId=299543, objectId=5a89299543d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a89299543d7, replyNumber=0, likeNumber=52, createdTime=2022-02-25, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a89299543d7, moduleTitle=拉斯克奖得主魏斯曼全新撰文，mRNA技术应用范围会加大，将颠覆药物开发模式, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=5a89299543d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442577, encodeId=5d3714425e75f, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=2021基因治疗与核酸药物开发高峰论坛 - 生物谷, objectType=article, longId=220834, objectId=cea62208346e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cea62208346e, replyNumber=0, likeNumber=35, createdTime=2021-11-24, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cea62208346e, moduleTitle=2021基因治疗与核酸药物开发高峰论坛 - 生物谷, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=cea62208346e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442576, encodeId=437214425e609, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=FDA干眼病治疗药物开发威廉亚洲博彩公司（草案） 2020, objectType=article, longId=208536, objectId=53572085368d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53572085368d, replyNumber=0, likeNumber=56, createdTime=2021-03-18, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53572085368d, moduleTitle=FDA干眼病治疗药物开发威廉亚洲博彩公司（草案） 2020, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=53572085368d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442575, encodeId=754a14425e593, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=Nat Med：新型人血吸虫感染模型为治疗和预防血吸虫病的快速药物开发铺平了道路, objectType=article, longId=201681, objectId=4f7a20168194, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f7a20168194, replyNumber=0, likeNumber=73, createdTime=2020-10-06, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f7a20168194, moduleTitle=Nat Med：新型人血吸虫感染模型为治疗和预防血吸虫病的快速药物开发铺平了道路, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=4f7a20168194)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442574, encodeId=d92b14425e455, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=精鼎医药全球患者咨询委员会落地中国，推动以患者为中心的药物开发, objectType=article, longId=200515, objectId=12af200515fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12af200515fe, replyNumber=0, likeNumber=65, createdTime=2020-09-12, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12af200515fe, moduleTitle=精鼎医药全球患者咨询委员会落地中国，推动以患者为中心的药物开发, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=12af200515fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442573, encodeId=eb2714425e321, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=初步调查排除了中国阿尔茨海默氏症药物开发者的学术造假行为, objectType=article, longId=184027, objectId=968518402e4c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=968518402e4c, replyNumber=0, likeNumber=51, createdTime=2019-12-04, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=968518402e4c, moduleTitle=初步调查排除了中国阿尔茨海默氏症药物开发者的学术造假行为, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=968518402e4c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442572, encodeId=165814425e2a8, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=诺华与微软达成协议，使用人工智能加速药物开发, objectType=article, longId=180388, objectId=8d4d180388ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d4d180388ee, replyNumber=0, likeNumber=53, createdTime=2019-10-04, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d4d180388ee, moduleTitle=诺华与微软达成协议，使用人工智能加速药物开发, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=8d4d180388ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442571, encodeId=d4f214425e175, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=临床研究革新势在必行：以数字化转型加速药物开发创新, objectType=article, longId=166791, objectId=c78d166e9160, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c78d166e9160, replyNumber=0, likeNumber=60, createdTime=2019-05-27, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c78d166e9160, moduleTitle=临床研究革新势在必行：以数字化转型加速药物开发创新, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=c78d166e9160)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442570, encodeId=211414425e051, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=PNAS：人脑脊液中的朊蛋白定量——助力朊病毒病药物开发, objectType=article, longId=163587, objectId=651416358e6f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=651416358e6f, replyNumber=0, likeNumber=60, createdTime=2019-04-05, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=651416358e6f, moduleTitle=PNAS：人脑脊液中的朊蛋白定量——助力朊病毒病药物开发, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=651416358e6f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442569, encodeId=c9181442569e4, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=从FDA批准的PD-(L)1类药物适应症看中国肿瘤免疫药物开发进展, objectType=article, longId=161087, objectId=39d816108ef7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39d816108ef7, replyNumber=0, likeNumber=82, createdTime=2019-02-27, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39d816108ef7, moduleTitle=从FDA批准的PD-(L)1类药物适应症看中国肿瘤免疫药物开发进展, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=39d816108ef7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442568, encodeId=9df0144256831, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=诺华与牛津大学合作利用人工智能进行药物开发, objectType=article, longId=158986, objectId=661e15898655, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=661e15898655, replyNumber=0, likeNumber=54, createdTime=2019-01-28, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=661e15898655, moduleTitle=诺华与牛津大学合作利用人工智能进行药物开发, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=661e15898655)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442567, encodeId=30e9144256e86, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=FDA公布药物开发现代化和提高效率的步骤, objectType=article, longId=151500, objectId=ed8815150050, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed8815150050, replyNumber=0, likeNumber=52, createdTime=2018-10-23, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed8815150050, moduleTitle=FDA公布药物开发现代化和提高效率的步骤, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=ed8815150050)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442566, encodeId=f3a9144256680, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=罕见病药物开发巨头Alexion的发展路径及启发, objectType=article, longId=144421, objectId=7a7f144421ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a7f144421ea, replyNumber=0, likeNumber=44, createdTime=2018-07-16, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a7f144421ea, moduleTitle=罕见病药物开发巨头Alexion的发展路径及启发, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=7a7f144421ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442565, encodeId=fa5a14425650c, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=Nature：人工智能助力药物开发, objectType=article, longId=140304, objectId=092114030498, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=092114030498, replyNumber=0, likeNumber=59, createdTime=2018-06-09, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=092114030498, moduleTitle=Nature：人工智能助力药物开发, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=092114030498)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442564, encodeId=16c814425644f, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=默克与英国癌症研究院和伦敦癌症研究所合作开展癌症药物开发, objectType=article, longId=126909, objectId=50f712690929, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50f712690929, replyNumber=0, likeNumber=56, createdTime=2018-01-20, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50f712690929, moduleTitle=默克与英国癌症研究院和伦敦癌症研究所合作开展癌症药物开发, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=50f712690929)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442563, encodeId=dc381442563a0, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=Oncotarget：化疗药物开发中tubulysin B衍生物利于克服癌症多重耐药性, objectType=article, longId=112282, objectId=45341122829e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45341122829e, replyNumber=0, likeNumber=75, createdTime=2017-09-09, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45341122829e, moduleTitle=Oncotarget：化疗药物开发中tubulysin B衍生物利于克服癌症多重耐药性, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=45341122829e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442562, encodeId=7faf14425626f, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=Oncotarget：miR-122-SOCS1反馈环在抗过敏和抗癌药物开发中具有潜力, objectType=article, longId=107130, objectId=e55f10e130aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e55f10e130aa, replyNumber=0, likeNumber=43, createdTime=2017-07-31, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e55f10e130aa, moduleTitle=Oncotarget：miR-122-SOCS1反馈环在抗过敏和抗癌药物开发中具有潜力, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=e55f10e130aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1442561, encodeId=2eb214425618b, content=<a href='/topic/show?id=7aa28e73211' target=_blank style='color:#2F92EE;'>#药物开发#</a>, objectTitle=Nat Microbiol：乙型肝炎治疗药物开发新近进展, objectType=article, longId=103000, objectId=a7981030009b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7981030009b, replyNumber=0, likeNumber=49, createdTime=2017-06-24, rootId=0, userName=ms1774076774505970, userId=92874938033, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7981030009b, moduleTitle=Nat Microbiol：乙型肝炎治疗药物开发新近进展, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=a7981030009b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] williamhill asia 话题小助手

药物开发

2020-05-29

williamhill asia 管理员 (审核中...)

前往app查看评论内容

#IBD# #炎症性肠病# #药物开发#

一作兼通讯，最新Nature系列综述：炎症性肠病药物开发的复杂性及其解决策略

2024-05-27发表于上海

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

“AlphaFold像地震一样，改变了游戏规则”，如今它开始在基础研究、药物开发上全面发力

2022-08-04

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

拉斯克奖得主魏斯曼全新撰文，mRNA技术应用范围会加大，将颠覆药物开发模式

2022-02-25

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

2021基因治疗与核酸药物开发高峰论坛 - 生物谷

2021-11-24

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

FDA干眼病治疗药物开发威廉亚洲博彩公司（草案） 2020

2021-03-18

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

Nat Med：新型人血吸虫感染模型为治疗和预防血吸虫病的快速药物开发铺平了道路

2020-10-06

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

精鼎医药全球患者咨询委员会落地中国，推动以患者为中心的药物开发

2020-09-12

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

初步调查排除了中国阿尔茨海默氏症药物开发者的学术造假行为

2019-12-04

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

诺华与微软达成协议，使用人工智能加速药物开发

2019-10-04

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

临床研究革新势在必行：以数字化转型加速药物开发创新

2019-05-27

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

PNAS：人脑脊液中的朊蛋白定量——助力朊病毒病药物开发

2019-04-05

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

从FDA批准的PD-(L)1类药物适应症看中国肿瘤免疫药物开发进展

2019-02-27

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

诺华与牛津大学合作利用人工智能进行药物开发

2019-01-28

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

FDA公布药物开发现代化和提高效率的步骤

2018-10-23

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

罕见病药物开发巨头Alexion的发展路径及启发

2018-07-16

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

Nature：人工智能助力药物开发

2018-06-09

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

默克与英国癌症研究院和伦敦癌症研究所合作开展癌症药物开发

2018-01-20

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

Oncotarget：化疗药物开发中tubulysin B衍生物利于克服癌症多重耐药性

2017-09-09

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

Oncotarget：miR-122-SOCS1反馈环在抗过敏和抗癌药物开发中具有潜力

2017-07-31

ms1774076774505970 (审核中...)

前往app查看评论内容

#药物开发#

Nat Microbiol：乙型肝炎治疗药物开发新近进展

2017-06-24

科室
- - 订阅+
  - 更多科室
工具
服务